Friday, May 29, 2026
ADVT 
International

Experts say Harris dominated in debate performance against Trump

Darpan News Desk The Canadian Press, 11 Sep, 2024 12:16 PM
  • Experts say Harris dominated in debate performance against Trump

Political experts say Kamala Harris was able to dominate Donald Trump by prodding the former Republican president over the crowd sizes at his rallies and the 2020 loss during a debate in Philadelphia Tuesday evening. 

"Harris going in had the most to gain and also the most to lose," said Allison Prasch, an expert on U.S. presidential rhetoric at the University of Wisconsin.

"I think she came in and really delivered an effective debate performance.” 

Tuesday’s matchup saw Harris push the former president on his record and bait him into tirades far from Trump's intended goals of focusing on immigration and the economy.

The former president's strategy is always to dominate the discussion and the stage, said former Republican strategist Chip Felkel. Harris was able to rattle Trump, Felkel added, and put her courtroom experience on display.

"I think for the first time in his political life since 2015 somebody figured out how to push back," Felkel said. "Not only to push back, but to dominate."

Trump criticized Harris's record, and her changing stance on issues like fracking and immigration.

Prasch said Trump's most effective criticism came during his closing argument, when he criticized Harris for not being able to achieve her current election promises in the more than three years she's been vice-president with the Biden administration. At that point, Prasch said, it was likely too little, too late.

Harris stayed focused and gave clear answers throughout the more than 90-minute debate. She also used her face and body to demonstrate when she thought statements from Trump were absurd or wrong, including the former president's unsubstantiated claims that immigrants in Ohio are eating their neighbours' dogs and cats.

"I think she gave a killer performance," said Saleena Temple, who attended a Democrat-organized watch party.

"I appreciate how she addressed him and put him in his place but in a tactful manner, a professional manner, a political manner. She looked presidential."

While Trump said he thought it was his best debate performance, Harris was rewarded at the end of the night with an endorsement from pop juggernaut Taylor Swift.

At a watch party a few blocks from where the debate was taking place, Matthew Lamorgese, chairman of the Philadelphia Young Republicans, said he believes voters know they can count on Trump's record.

"Under Donald Trump, we had a strong economy, low inflation, and a secure border," Lamorgese said. "We had world peace …. That's what you are going to see."

Experts say Harris has proven a problematic opponent for Trump so far on the campaign trail. Lamorgese said he wasn't worried about the vice-president's performance against the Republican former president.

"Kamala has a different set of issues but issues nonetheless," Lamorgese said. 

Tuesday's debate was a stark contrast to the first presidential debate in June, where Trump easily dominated an unclear and uneasy performance by Joe Biden, which ultimately led to the president dropping from the race.

The race for the White House remains razor thin after a tumultuous summer that has included an assassination attempt of the former president and a wholly reimagined Democratic ticket. 

Experts say many would-be voters are just starting to tune in to the campaigns.

Pennsylvania, where the debate took place, has become the forefront battleground state where both parties are trying to gain favour. Trump took it in 2016 before it swung back to Biden in 2020 — both by narrow margins.

Matthew Lebo, a specialist in U.S. politics at Western University in London, Ont., said Harris may see a bump in approval after the debate but she still has a lot of work to do ensuring voters know her policies and personality ahead of November. 

The debate was light on policy particulars. Trump continued his threats to not defend NATO members that don't meet the alliance's defence spending targets, of which Canada is one.

Prime Minister Justin Trudeau promised in July to meet the spending target, which is the equivalent of two per cent of gross domestic product, by 2032.

Harris talked about America's ongoing support for the defence alliance and criticized Trump's relationship with Vladimir Putin and close ties to Hungarian Prime Minister Viktor Orbán. 

Whoever wins the election will be in power during the review of the Canada-United States-Mexico trade pact in 2026.

Harris was one of 10 U.S. senators to vote against the trilateral agreement under Trump, saying it didn’t do enough to protect American workers or the environment.

Trump repeated his plans to increase tariffs on imports and Harris spoke about ensuring American jobs remain in the U.S.

"Tariffs would certainly hurt trade with Canada if he ever went through with that," Lebo said. 

Canadians should be most concerned about Trump's continued denials of responsibility for any role in the Jan. 6 attack on Capitol Hill and what that means for democracy, Lebo said.

"That's just dangerous and Canadians, on the border of the United States, need a stable democracy there," Lebo said.

"And he's just undermining that."

MORE International ARTICLES

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population
The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

WATCH: Why are Farmers Up in Arms Against India's Government ?

WATCH: Why are Farmers Up in Arms Against India's Government ?
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws. 

WATCH: Why are Farmers Up in Arms Against India's Government ?

White House still planning holiday parties, despite warnings

White House still planning holiday parties, despite warnings
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.

White House still planning holiday parties, despite warnings

3rd major COVID-19 vaccine shown to be effective and cheaper

3rd major COVID-19 vaccine shown to be effective and cheaper
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

3rd major COVID-19 vaccine shown to be effective and cheaper

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer seeking emergency use of its COVID-19 vaccine in US
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Pfizer seeking emergency use of its COVID-19 vaccine in US